NDC11 55910096307
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 55910-0963-07 | 55910-0963 |
| 55910-0963-7 | 55910-0963 |
| 55910-963-07 | 55910-963 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold Sore Fever Blister Treatment | DOCOSANOL | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 4286c19b-8c81-40f6-8d97-cfebba87c174 | 2025-10-10 | Warnings | 55910-963-07 55910-963 55910096307 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.